0576-88813233
Rostafuroxin(PST 2238)是一种抗高血压化合物Na+K ATPase拮抗剂;IC50为1.5 nM。
中文别名:
(3β,5β,14β)-21,23-Epoxy-24-Norchola-20,22-diene-3,14,17-triol
物化属性:
密度:1.226
沸点:451.3°C at 760 mmHg
折射率:1.59
闪光点:226.7°C
[1]. Quadri L, et al. 17 beta-(3-furyl)-5 beta-androstane-3 beta, 14 beta, 17 alpha-triol (PST 2238). A very potent antihypertensive agent with a novel mechanism of action. J Med Chem. 1997 May 23;40(11):1561-4.
[2]. Ferrari P, et al. PST 2238: A new antihypertensive compound that modulates Na,K-ATPase in genetic hypertension. J Pharmacol Exp Ther. 1999 Mar;288(3):1074-83.
[3]. Ferrari P, et al. Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R529-35.
版权所有 Copyright(C) 2018-2024 台州市科瑞生物技术有限公司